Health Hepatic Cirrhosis Market Evolving at a Rapid Pace, Predicts DelveInsight | Key Companies Active in… James Pereira Apr 28, 2023 <!-- Name:DistributionId Value:8826847 --> <!--… Read More...
Health Akero Presents New Analysis of Phase 2a BALANCED Study Data Showing Additional Qualitative Evidence… James Pereira Nov 12, 2021 Most EFX-treated patients with end-of-treatment biopsies showed improvements in features of steatohepatitis (35 of 40;… Read More...
Health Akero Therapeutics Presents at the American Diabetes Association’s 81st Scientific Sessions,… James Pereira Jun 26, 2021 SOUTH SAN FRANCISCO, Calif., June 25, 2021 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a… Read More...